GOCO · Gohealth, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - |
| Cost of Revenue | $8.32M | - | $20.09M | $32.41M | $39.27M | - | $19.68M | $20.68M | $38.01M | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $21.69M | - | $27.69M | $21.94M | $22.66M | - | $17.14M | $16.40M | $16.92M | - |
| Total Operating Expenses | $46.71M | - | $322.10M | $193.43M | $214.30M | - | $160.96M | $146.48M | $189.63M | - |
| D&A | $307.0K | - | - | - | $2.96M | - | - | - | $2.73M | - |
| Operating Income | ($34.79M) | - | ($287.92M) | ($99.39M) | $6.67M | - | ($42.67M) | ($40.61M) | ($4.03M) | - |
| Interest Expense | $30.79M | - | $24.76M | $16.95M | $17.95M | - | $19.09M | $18.10M | $17.95M | - |
| Income Tax | $712.0K | - | ($486.0K) | ($353.0K) | $1.10M | - | ($11.0K) | ($40.0K) | ($71.0K) | - |
| Net Income | ($37.17M) | - | ($165.85M) | ($54.28M) | ($4.41M) | - | $6.78M | ($26.00M) | ($9.22M) | - |
| EPS - Basic | ($2.36) | - | ($11.80) | ($5.10) | ($0.52) | - | $0.58 | ($2.70) | ($1.04) | - |
| EPS - Diluted | ($2.36) | - | ($11.80) | ($5.10) | ($0.52) | - | $0.46 | ($2.70) | ($1.04) | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $39.88M | $32.90M | $32.08M | $35.59M | $22.15M | $40.92M | $35.53M | $14.12M | $97.82M | $90.81M |
| Accounts Receivable | $1.0K | $72.0K | $2.0K | $143.0K | $5.90M | $4.45M | $6.86M | $13.47M | $9.23M | $250.0K |
| Inventory | - | - | - | - | - | - | - | - | - | - |
| Accounts Payable | $8.47M | $6.92M | $11.85M | $19.89M | $20.30M | $14.59M | $15.29M | $10.07M | $5.77M | $17.70M |
| Current Assets | $264.90M | $285.79M | $287.46M | $288.80M | $260.91M | $400.41M | $334.04M | $301.17M | $397.10M | $476.44M |
| Total Assets | $917.92M | $987.38M | $1.03B | $1.31B | $1.38B | $1.49B | $1.34B | $1.26B | $1.40B | $1.50B |
| Current Liabilities | $130.24M | $141.50M | $175.68M | $185.00M | $233.40M | $338.05M | $281.97M | $234.04M | $300.00M | $370.01M |
| Long-term Debt | $650.76M | $636.74M | $581.84M | $560.00M | $446.40M | $447.87M | $416.33M | $413.33M | $410.32M | $422.70M |
| Total Liabilities | - | - | - | - | - | - | - | - | - | - |
| Stockholders' Equity | $2.13M | $37.87M | $68.17M | $191.78M | $241.63M | $241.84M | $212.04M | $202.73M | $225.88M | $231.01M |
| Retained Earnings | ($717.50M) | ($680.33M) | ($647.74M) | ($481.89M) | ($427.62M) | ($423.21M) | ($448.72M) | ($455.49M) | ($429.50M) | ($420.28M) |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $6.99M | - | - | - | ($12.40M) | - | - | - | $12.51M | - |
| Investing Cash Flow | $0 | - | - | - | ($3.05M) | - | - | - | ($4.56M) | - |
| Financing Cash Flow | ($25.0K) | - | - | - | ($3.20M) | - | - | - | ($942.0K) | - |
| CapEx | $0 | - | - | - | $3.05M | - | - | - | $4.56M | - |
| Free Cash Flow | $6.99M | - | - | - | ($15.45M) | - | - | - | $7.96M | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | - | - | - | - | - | - | - | - | - | - |
| EBITDA margin | - | - | - | - | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - | - | - |
| Free cash flow margin | - | - | - | - | - | - | - | - | - | - |
| FCF / Net income | -0.19 | - | - | - | 3.51 | - | - | - | -0.86 | - |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | - | - | - | - | - | - | - | - | - | - |
| Effective tax rate | - | - | - | - | - | - | -0.2% | - | - | - |
| Return on assets | -4.0% | - | -16.1% | -4.1% | -0.3% | - | 0.5% | -2.1% | -0.7% | - |
| Return on equity | -1744.3% | - | -243.3% | -28.3% | -1.8% | - | 3.2% | -12.8% | -4.1% | - |
| Return on invested capital | -4.2% | - | -35.0% | -10.4% | 0.8% | - | -6.8% | -5.2% | -0.5% | - |
| Liquidity | ||||||||||
| Current ratio | 2.03 | 2.02 | 1.64 | 1.56 | 1.12 | 1.18 | 1.18 | 1.29 | 1.32 | 1.29 |
| Quick ratio | 2.03 | 2.02 | 1.64 | 1.56 | 1.12 | 1.18 | 1.18 | 1.29 | 1.32 | 1.29 |
| Cash ratio | 0.31 | 0.23 | 0.18 | 0.19 | 0.09 | 0.12 | 0.13 | 0.06 | 0.33 | 0.25 |
| Leverage | ||||||||||
| Debt / Equity | 305.38 | 16.81 | 8.54 | 2.92 | 1.85 | 1.85 | 1.96 | 2.04 | 1.82 | 1.83 |
| Debt / Assets | 0.71 | 0.64 | 0.56 | 0.43 | 0.32 | 0.30 | 0.31 | 0.33 | 0.29 | 0.28 |
| Debt / EBITDA | - | - | - | - | 46.35 | - | - | - | - | - |
| Interest coverage | -1.1x | - | -11.6x | -5.9x | 0.4x | - | -2.2x | -2.2x | -0.2x | - |
| Equity multiplier | 430.74 | 26.07 | 15.12 | 6.84 | 5.72 | 6.15 | 6.33 | 6.20 | 6.18 | 6.49 |
| Liabilities / Assets | - | - | - | - | - | - | - | - | - | - |
| Efficiency | ||||||||||
| Asset turnover | - | - | - | - | - | - | - | - | - | - |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | - | - | - | - | - | - | - | - | - | - |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | 372d | - | 215d | 224d | 189d | - | 283d | 178d | 55d | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | 20.4x | - | - | - |
| P / B | 11.5x | - | 1.0x | 0.3x | 0.5x | - | 0.6x | 0.5x | 0.5x | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | 57.3x | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | - | - | -574.7% | -144.7% | - | - | -12.4% | 23.4% | 29.9% | - |
| Net income growth (YoY) | -743.3% | - | - | -108.8% | 52.2% | - | - | 10.2% | -0.4% | - |
| EPS growth (YoY) | -353.8% | - | - | -88.9% | 50.0% | - | - | 17.4% | 7.1% | - |
| EPS CAGR (3y) | - | - | - | - | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - | - | - | - | -56.4% | - |
| FCF CAGR (5y) | -19.0% | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | -99.1% | -84.3% | -67.9% | -5.4% | 7.0% | 4.7% | -7.0% | -18.9% | -14.3% | -14.0% |
Peer comparison
Same SIC group: Insurance Agents, Brokers & Service
Comparing GoHealth against the 5 most active filers in the same SIC group.